Upadacitinib 15 MG [Rinvoq] clinical trials

A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis

This study is looking at how a medicine called Upadacitinib (Rinvoq) affects psoriatic arthritis, especially when it involves the spine. Researchers want to see if it helps reduce symptoms and improve life for people with this condition. It's a randomised trial comparing the medicine to a dummy pill.